News list for "190.8"
On May 23rd, Nomura Research and Development reported that Rongchang Biological (09995.HK) 's placement of new H shares is good for the group's financial situation. The bank believes that the current strong market sentiment for biotechnology companies provides a good time for the group to issue, and at the same time, 800 million the proceeds of the Hong Kong dollar placement will strengthen the group's limited cash position. The bank believes that the outlook for asset licensing has also become ...
5月23日讯，野村发研报指，荣昌生物(09995.HK)配售新H股利好集团财务状况。该行相信，目前市场对生物科技公司的强烈情绪，为集团提供了良好的发行时机，同时，8亿港元配售所得，将加强集团有限的现金状况。该行认为，资产外授许可的前景亦变得更光明，因此上调集团目标价190.8%，由16.37港元升至47.6港元。暂维持“中性”评级。
According to Tree News monitoring, yesterday IBIT net outflow of $190.80 million, ETHA net inflow of $44.50 million.
